164 related articles for article (PubMed ID: 31416738)
1. Synthesis, molecular docking, and QSAR study of bis-sulfonamide derivatives as potential aromatase inhibitors.
Leechaisit R; Pingaew R; Prachayasittikul V; Worachartcheewan A; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Med Chem; 2019 Oct; 27(19):115040. PubMed ID: 31416738
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, molecular docking, and QSAR study of sulfonamide-based indoles as aromatase inhibitors.
Pingaew R; Mandi P; Prachayasittikul V; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2018 Jan; 143():1604-1615. PubMed ID: 29137864
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and molecular docking of N,N'-disubstituted thiourea derivatives as novel aromatase inhibitors.
Pingaew R; Prachayasittikul V; Anuwongcharoen N; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Chem; 2018 Sep; 79():171-178. PubMed ID: 29758407
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors.
Pingaew R; Prachayasittikul V; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Med Chem; 2015 Jul; 23(13):3472-80. PubMed ID: 25934226
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors.
Fantacuzzi M; De Filippis B; Gallorini M; Ammazzalorso A; Giampietro L; Maccallini C; Aturki Z; Donati E; Ibrahim RS; Shawky E; Cataldi A; Amoroso R
Eur J Med Chem; 2020 Jan; 185():111815. PubMed ID: 31732252
[TBL] [Abstract][Full Text] [Related]
6. Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers.
Ghorab MM; Alsaid MS; Al-Ansary GH; Abdel-Latif GA; Abou El Ella DA
Eur J Med Chem; 2016 Nov; 124():946-958. PubMed ID: 27770735
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking and QSAR studies of aromatase inhibitor androstenedione derivatives.
Roy PP; Roy K
J Pharm Pharmacol; 2010 Dec; 62(12):1717-28. PubMed ID: 21054398
[TBL] [Abstract][Full Text] [Related]
8. Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors.
Dai Y; Wang Q; Zhang X; Jia S; Zheng H; Feng D; Yu P
Eur J Med Chem; 2010 Dec; 45(12):5612-20. PubMed ID: 20926163
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors.
Di Matteo M; Ammazzalorso A; Andreoli F; Caffa I; De Filippis B; Fantacuzzi M; Giampietro L; Maccallini C; Nencioni A; Parenti MD; Soncini D; Del Rio A; Amoroso R
Bioorg Med Chem Lett; 2016 Jul; 26(13):3192-3194. PubMed ID: 27161804
[TBL] [Abstract][Full Text] [Related]
10. Discrete Fourier Transform-Based Multivariate Image Analysis: Application to Modeling of Aromatase Inhibitory Activity.
Barigye SJ; Freitas MP; Ausina P; Zancan P; Sola-Penna M; Castillo-Garit JA
ACS Comb Sci; 2018 Feb; 20(2):75-81. PubMed ID: 29297675
[TBL] [Abstract][Full Text] [Related]
11. Novel triazole-tetrahydroisoquinoline hybrids as human aromatase inhibitors.
Chamduang C; Pingaew R; Prachayasittikul V; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Chem; 2019 Dec; 93():103327. PubMed ID: 31614285
[TBL] [Abstract][Full Text] [Related]
12. Aromatase inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules.
Ghorab MM; Alsaid MS; Samir N; Abdel-Latif GA; Soliman AM; Ragab FA; Abou El Ella DA
Eur J Med Chem; 2017 Jul; 134():304-315. PubMed ID: 28427017
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships and docking studies of synthetic 2-arylindole derivatives determined with aromatase and quinone reductase 1.
Prior AM; Yu X; Park EJ; Kondratyuk TP; Lin Y; Pezzuto JM; Sun D
Bioorg Med Chem Lett; 2017 Dec; 27(24):5393-5399. PubMed ID: 29153737
[TBL] [Abstract][Full Text] [Related]
14. Docking and 3D-QSAR studies of diverse classes of human aromatase (CYP19) inhibitors.
Roy PP; Roy K
J Mol Model; 2010 Oct; 16(10):1597-616. PubMed ID: 20195667
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Biological Evaluation of New Azole Derivatives as Potent Aromatase Inhibitors with Potential Effects against Breast Cancer.
Kalalinia F; Jouya M; Komachali AK; Aboutourabzadeh SM; Karimi G; Behravan J; Abnous K; Etemad L; Kamali H; Hadizadeh F
Anticancer Agents Med Chem; 2018; 18(7):1016-1024. PubMed ID: 29336269
[TBL] [Abstract][Full Text] [Related]
16. QSAR modeling of aromatase inhibitory activity of 1-substituted 1,2,3-triazole analogs of letrozole.
Nantasenamat C; Worachartcheewan A; Prachayasittikul S; Isarankura-Na-Ayudhya C; Prachayasittikul V
Eur J Med Chem; 2013 Nov; 69():99-114. PubMed ID: 24012714
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors.
Giampietro L; Gallorini M; Gambacorta N; Ammazzalorso A; De Filippis B; Della Valle A; Fantacuzzi M; Maccallini C; Mollica A; Cataldi A; Nicolotti O; Amoroso R
Eur J Med Chem; 2021 Nov; 224():113737. PubMed ID: 34365129
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling evaluation of non-steroidal aromatase inhibitors.
Narayana BL; Pran Kishore D; Balakumar C; Rao KV; Kaur R; Rao AR; Murthy JN; Ravikumar M
Chem Biol Drug Des; 2012 May; 79(5):674-82. PubMed ID: 22129073
[TBL] [Abstract][Full Text] [Related]
19. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel aromatase inhibitors using a homogeneous time-resolved fluorescence assay.
Ji JZ; Lao KJ; Hu J; Pang T; Jiang ZZ; Yuan HL; Miao JS; Chen X; Ning SS; Xiang H; Guo YM; Yan M; Zhang LY
Acta Pharmacol Sin; 2014 Aug; 35(8):1082-92. PubMed ID: 25047514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]